COVID-19 IgM/IgG Antibody Rapid Test

This on-site rapid test detects antibodies produced when infected by the COVID-19 virus
(Coronavirus Disease), caused by 2019-nCoV (SARS-CoV-2).

COVID-19 Rapid Test Kit2020-07-08T15:03:34+00:00

COVID-19 IgM/IgG Antibody Rapid Test

How are you navigating the complex issue of continuing or re-starting operations while prioritizing the health and safety of your workforce while COVID-19 is still a growing concern?

Testing has been a key component of many companies’ continuity strategies. At SBL, we’re committed to delivering high quality, on-site testing technologies that support the safety and efficiency of your workforce – now and in the future. Our partnerships with top-tier manufacturers have allowed us to offer our clients reliable and accurate COVID-19 IgM/IgG Antibody Rapid Tests.

The test comes with the proper channels to aid in reporting and tracking results through a user-friendly mobile app that allows for better overall comprehension of your testing program. The app helps employers manage which employees have been tested, as well as, when and what their status is in real time. When you choose SBL, you also receive access to our support portal and our team of subject matter experts available to answer your questions.

Learn about our COVID-19 IgM/IgG Antibody Rapid Test.

SBL can help integrate workplace testing into your COVID-19 business continuity strategy.

Device Features

  • Detects antibodies 5-7 days after symptoms first appear
  • Shows clear, easy-to read results within 15 minutes
  • Cost-effective
  • Easy to administer by health personnel (requires handling of blood sample)
  • All-in-one kit contains all required components

How Does It Work

Estimate of general biomarker levels during the typical timecourse of COVID-19/SARS-CoV-2 infection. Data from Liu et al. and Li et al. Please note that this is purely illustrative and should not be used as a primary reference.

Our COVID-19 Antibody Tests are simple to use, and our team is here to support any questions your test administrators may have.

Antibody testing is used to detect the antibodies an infected or exposed person’s body creates in response to the COVID-19 virus. This point-of-care lateral flow immunoassay test detects IgM and IgG antibodies against the COVID-19 virus in human blood, detecting patients at different infection stages, typically 5-7 days after symptoms first appear. It does not detect the COVID-19 virus itself, but the antibodies produced to fight the virus. Our antibody test produces results within 15 minutes as opposed to days or weeks for nasopharyngeal swab tests.

  • IgM provides the first line of defense during viral infections, followed by the generation of adaptive, high affinity IgG responses for longer-term immunity and immunological memory.
  • The detection of IgM antibodies tends to indicate a recent exposure to COVID-19, whereas detection of IgG antibodies indicates a later stage of infection

Interpreting Results

Workplace testing is only effective if results are correctly reported and interpreted. Our guide below helps business leaders make informed decisions based on data.

How Do I Purchase?

Simply complete our quote request form and a member of our team will reach out to you with a quote as soon as possible.

Due to the elevated demand for antibody tests, orders will be taken on a first come first served basis. All orders must be pre-paid before shipment.